Study of effects on the retina and the choroid of intravitreal ranibizmab injection in patients with macular edema due to central retinal vein occlusion.

Not Applicable

• Conditions: central retinal vein occlusion

• Registration Number: JPRN-UMIN000029921
• Lead Sponsor: agasaki University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-11-10
• Study Completion: 2017-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who underwent the pan-retinal photocoagulation within 3 months. 2.Patients who underwent photocoagulation treatment for macular edema within 3 months. 3.Patients treated with steroids to intraocular within 3 months. 4.Patients who underwent anti-VEGF injection for macular edema within 3 months. 3.Patients treated with steroids to intraocular within 3 months. 5.The patients with a history of hypersensitivity to the study drug. 6.Patients who developed heart and cerebrovascular disease severe within 6 months. 7.Patients attending physician was deemed inappropriate as a subject.

Study & Design

• Study Type: Interventional
• Study Design: Not specified